Potential of Ramalin and Its Derivatives for the Treatment of Alzheimer’s Disease

The pathogenesis of Alzheimer’s disease (AD) is still unclear, and presently there is no cure for the disease that can be used for its treatment or to stop its progression. Here, we investigated the therapeutic potential of ramalin (isolated from the Antarctic lichen, <i>Ramalina terebrata<...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tai Kyoung Kim, Ju-Mi Hong, Kyung Hee Kim, Se Jong Han, Il-Chan Kim, Hyuncheol Oh, Joung Han Yim
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/56a4c1ebaf89466d94994460a20a0aca
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:56a4c1ebaf89466d94994460a20a0aca
record_format dspace
spelling oai:doaj.org-article:56a4c1ebaf89466d94994460a20a0aca2021-11-11T18:27:38ZPotential of Ramalin and Its Derivatives for the Treatment of Alzheimer’s Disease10.3390/molecules262164451420-3049https://doaj.org/article/56a4c1ebaf89466d94994460a20a0aca2021-10-01T00:00:00Zhttps://www.mdpi.com/1420-3049/26/21/6445https://doaj.org/toc/1420-3049The pathogenesis of Alzheimer’s disease (AD) is still unclear, and presently there is no cure for the disease that can be used for its treatment or to stop its progression. Here, we investigated the therapeutic potential of ramalin (isolated from the Antarctic lichen, <i>Ramalina terebrata</i>), which exhibits various physiological activities, in AD. Specifically, derivatives were synthesized based on the structure of ramalin, which has a strong antioxidant effect, BACE-1 inhibition activity, and anti-inflammatory effects. Therefore, ramalin and its derivatives exhibit activity against multiple targets associated with AD and can serve as potential therapeutic agents for the disease.Tai Kyoung KimJu-Mi HongKyung Hee KimSe Jong HanIl-Chan KimHyuncheol OhJoung Han YimMDPI AGarticleAlzheimer’s diseaseramalinderivativestherapeutic potentialantioxidantβ-secrataseOrganic chemistryQD241-441ENMolecules, Vol 26, Iss 6445, p 6445 (2021)
institution DOAJ
collection DOAJ
language EN
topic Alzheimer’s disease
ramalin
derivatives
therapeutic potential
antioxidant
β-secratase
Organic chemistry
QD241-441
spellingShingle Alzheimer’s disease
ramalin
derivatives
therapeutic potential
antioxidant
β-secratase
Organic chemistry
QD241-441
Tai Kyoung Kim
Ju-Mi Hong
Kyung Hee Kim
Se Jong Han
Il-Chan Kim
Hyuncheol Oh
Joung Han Yim
Potential of Ramalin and Its Derivatives for the Treatment of Alzheimer’s Disease
description The pathogenesis of Alzheimer’s disease (AD) is still unclear, and presently there is no cure for the disease that can be used for its treatment or to stop its progression. Here, we investigated the therapeutic potential of ramalin (isolated from the Antarctic lichen, <i>Ramalina terebrata</i>), which exhibits various physiological activities, in AD. Specifically, derivatives were synthesized based on the structure of ramalin, which has a strong antioxidant effect, BACE-1 inhibition activity, and anti-inflammatory effects. Therefore, ramalin and its derivatives exhibit activity against multiple targets associated with AD and can serve as potential therapeutic agents for the disease.
format article
author Tai Kyoung Kim
Ju-Mi Hong
Kyung Hee Kim
Se Jong Han
Il-Chan Kim
Hyuncheol Oh
Joung Han Yim
author_facet Tai Kyoung Kim
Ju-Mi Hong
Kyung Hee Kim
Se Jong Han
Il-Chan Kim
Hyuncheol Oh
Joung Han Yim
author_sort Tai Kyoung Kim
title Potential of Ramalin and Its Derivatives for the Treatment of Alzheimer’s Disease
title_short Potential of Ramalin and Its Derivatives for the Treatment of Alzheimer’s Disease
title_full Potential of Ramalin and Its Derivatives for the Treatment of Alzheimer’s Disease
title_fullStr Potential of Ramalin and Its Derivatives for the Treatment of Alzheimer’s Disease
title_full_unstemmed Potential of Ramalin and Its Derivatives for the Treatment of Alzheimer’s Disease
title_sort potential of ramalin and its derivatives for the treatment of alzheimer’s disease
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/56a4c1ebaf89466d94994460a20a0aca
work_keys_str_mv AT taikyoungkim potentialoframalinanditsderivativesforthetreatmentofalzheimersdisease
AT jumihong potentialoframalinanditsderivativesforthetreatmentofalzheimersdisease
AT kyungheekim potentialoframalinanditsderivativesforthetreatmentofalzheimersdisease
AT sejonghan potentialoframalinanditsderivativesforthetreatmentofalzheimersdisease
AT ilchankim potentialoframalinanditsderivativesforthetreatmentofalzheimersdisease
AT hyuncheoloh potentialoframalinanditsderivativesforthetreatmentofalzheimersdisease
AT jounghanyim potentialoframalinanditsderivativesforthetreatmentofalzheimersdisease
_version_ 1718431823448506368